SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt incorporates subsidiary company

27 Mar 2019 Evaluate

Wockhardt has incorporated wholly owned subsidiary namely ‘Wockhardt Medicines’ (WML) with effect from March 25, 2019. The main object of WML is pharmaceuticals business is to carry on either as manufacturers, processors, traders, dealers, exporters, importers warehousing agents, commission agents etc.

The WML is incorporated with an Authorised Share Capital of Rs 10 lakh. The Company has subscribed to 100% shareholding comprising of 50,000 equity shares of Rs 10 each i.e. Rs 5 lakh in WML.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×